Literature DB >> 14947006

Intra-articular hydrocortisone acetate in rheumatoid arthritis.

G D KERSLEY, M H L DESMARAIS.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX/hormones; ARTHRITIS, RHEUMATOID/therapy

Mesh：

Substances：

Year:  1952        PMID： 14947006     DOI： 10.1016/s0140-6736(52)92383-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Effectiveness of methylprednisolone and prednisolone tertiary-butylacetate intra-articularly in rheumatoid arthritis: a comparative study.

Authors:  J F WOODBURY; A BIECHL
Journal:  Can Med Assoc J       Date:  1960-10-15       Impact factor: 8.262

2.  Hydrocortisone tertiary-butylacetate for intra-articular therapy in rheumatic diseases.

Authors:  A M AHERN; O MACHEK; J ZUCKNER
Journal:  Ann Rheum Dis       Date:  1956-09       Impact factor: 19.103

3.  Serial studies of synovial fluid in evaluating intra-articular agents.

Authors:  F K AUSTEN; E CALKINS
Journal:  Ann Rheum Dis       Date:  1955-09       Impact factor: 19.103

4.  Local anti-rheumatic effectiveness of higher esters and analogues of hydrocortisone.

Authors:  J L HOLLANDER; E M BROWN; R A JESSAR; L UDELL; N SMUKLER; M A BOWIE
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

5.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1954-04-10

6.  [Articular infections due to intra-articular corticosteroid therapy].

Authors:  R Plaue; P Hinz
Journal:  Arch Orthop Unfallchir       Date:  1969

7.  A high dose (up to 200 mg) tolerance and efficacy study of intra-articular rimexolone (Org 6216) in rheumatoid synovitis of the knee.

Authors:  G Gevers; J Dequeker; M van Holsbeeck; E van Vliet-Daskalopoulou
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.